Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study.
Glazyrina A., Zholobova E., Iakovleva E., Bobkova P., Krasnaya E., Kovygina K., Romanova O., Blyuss O., Tutelman K., Petrova P., Bairashevskaia A., Rumyantsev M., Korsunskiy AA., Kondrikova E., Nargizyan A., Yusupova V., Korobyants E., Sologub A., Kurbanova S., Suvorov A., Sigfrid L., Buonsenso D., Peroni DG., McArdle AJ., Comberiati P., Munblit D.
BackgroundEven though the incidence of Multisystem Inflammatory Syndrome in children (MIS-C) is decreasing cases are still reported across the world. Studying the consequences of MIS-C enhances our understanding of the disease's prognosis. The objective of this study was to assess short- and medium-term clinical outcomes of MIS-C.MethodsProspective observational cohort study at Municipal Children's Hospital Morozovskaya, Moscow, Russia. All children meeting the Royal College of Paediatrics and Child Health (RCPCH), Centers for Disease Control and Prevention (CDC), or the World Health Organization (WHO) MIS-C case definition admitted to the hospital between 17 May and 26 October 2020 were included in the study. All survivors were invited to attend a clinic at 2 and 6 weeks after hospital discharge.Results37 children median age 6 years (interquartile range [IQR] 3.3-9.4), 59.5% (22/37) boys were included in the study. 48.6% (18/37) of patients required ICU care. One child died. All children had increased levels of systemic inflammatory markers during the acute event. Echocardiographic investigations identified abnormal findings in 35.1% (13/37) of children. 5.6% (2/36) of children were presenting with any symptoms six weeks after discharge. By six weeks the inflammatory markers were within the reference norms in all children. The echocardiographic evaluation showed persistent coronary dilatation in one child.ConclusionsDespite the severity of their acute MIS-C, the majority of children in our cohort fully recovered with none having elevated laboratory markers of inflammation at 6 weeks, few (